Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
暂无分享,去创建一个
N. Prasad | A. Kaul | D. Bhadauria | R. Kushwaha | M. Behera | B. Yadav | S. Bansal | M. Yachha | Ankita Singh | N. Manhas | D. Yadav | Sonam Gautam | S. Gautam